Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib and Chemotherapy Followed by Transplant in Adult Ph+ ALL
NCT01256398Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2010
- Primary completion
- Nov 2017
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dasatinib in Acute lymphoblastic leukemia, Philadelphia chromosome positive, sponsored by National Cancer Institute. Started Dec 2010; status: completed.
02
Drugs
dasatinib
03
Conditions
Acute lymphoblastic leukemia, Philadelphia chromosome positive
Beyond the preview
Go deeper on NCT01256398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256398.